Loading organizations...
Loading organizations...
Gene therapy company focused on rare diseases and animal model validation.
Lingyi Biology has raised $30.3M across 2 funding rounds.
Lingyi Biology has raised $30.3M in total across 2 funding rounds.
Lingyi Biology has raised $30.3M in total across 2 funding rounds.
Lingyi Biology's investors include Efung Capital, Hongshan Capital Group (Sequoia Capital China), Gu Cui Ping, Sun Linghao.
Lingyi Biology has raised $30.3M across 2 funding rounds. Most recently, it raised $14.5M Series A in May 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 6, 2023 | $14.5M Series A | Efung Capital | Hongshan Capital Group (Sequoia Capital China) |
| Feb 28, 2022 | $15.8M Pre-Series A | Gu Cui Ping, Sun Linghao |